Inventor · disambiguated record
Andrew Mcmurtrie Mason
Also filed as: MASON ANDREW · MASON ANDREW M · MASON ANDREW MCMURTRIE
23 granted patents·19 pending applications·173 citations·filing 1999–2015
95Inventor score
Files withGLAXO GROUP LTD17SMITHKLINE BEECHAM CORP5BORTHWICK ALAN DAVID3HATLEY RICHARD JONATHAN DANIEL2CAMPBELL MATTHEW1
Top patents by PatentIndex Score
42 records- 0193US7919492B2CompoundsGLAXO GROUP LTD·Filed 2010·Granted Apr 5, 2011·13 cites·4 claims
- 0293US7550462B2Piperazinediones as oxytocin receptor antagonistsGLAXO GROUP LTD·Filed 2005·Granted Jun 23, 2009·15 cites·6 claims
- 0391US9408851B2CompoundsGLAXO GROUP LTD·Filed 2015·Granted Aug 9, 2016·6 cites·2 claims
- 0489US8742099B2CompoundsGLAXO GROUP LTD·Filed 2013·Granted Jun 3, 2014·7 cites·1 claims
- 0589US8202864B2CompoundsBORTHWICK ALAN DAVID·Filed 2011·Granted Jun 19, 2012·11 cites·4 claims
- 0686US7226929B2Pyrrolidin-2-one derivatives as inhibitors of factor xaSMITHKLINE BEECHAM CORP·Filed 2006·Granted Jun 5, 2007·4 cites·11 claims
- 0785US8367673B2Substituted diketopiperazines as oxytocin antagonistsGLAXO GROUP LTD·Filed 2009·Granted Feb 5, 2013·8 cites·11 claims
- 0884US7205333B2Multivalent neuraminidase inhibitor conjugatesWU WEN-YANG·Filed 2001·Granted Apr 17, 2007·31 cites·39 claims
- 0983US8541579B2Substituted diketopiperazines as oxytocin antagonistsGLAXO GROUP LTD·Filed 2012·Granted Sep 24, 2013·6 cites·1 claims
- 1083US7732622B2Naphthalene derivativesGLAXO GROUP LTD·Filed 2008·Granted Jun 8, 2010·5 cites·3 claims
- 1183US7282497B2Pyrrolidin-2-one derivatives as inhibitors of factor xaGLAXO GROUP LTD·Filed 2006·Granted Oct 16, 2007·2 cites·12 claims
- 1281US7514437B2Substituted diketopiperazines as oxytocin antagonistsSMITHKLINE BEECHAM CORP·Filed 2002·Granted Apr 7, 2009·15 cites·12 claims
- 1374US7084139B2Pyrrolidin-2-one derivatives as inhibitors of factor XaSMITHKLINE BEECHAM CORP·Filed 2002·Granted Aug 1, 2006·4 cites·11 claims
- 1470US7186717B2Pyrrolidine derivatives as Factor Xa inhibitorsGLAXO GROUP LTD·Filed 2002·Granted Mar 6, 2007·4 cites·13 claims
- 1568US6867192B1Compounds useful in the treatment of inflammatory diseasesFiled 1999·Granted Mar 15, 2005·34 cites·20 claims
- 1667US2009247541A1Novel compoundsBORTHWICK ALAN DAVID·Filed 2009·Application pending·0 cites
- 1766US7179835B22-(3-sulfonylamino-2-oxopyrrolidin-1-yl)propanamides as factor xa inhibitorsGLAXO GROUP LTD·Filed 2002·Granted Feb 20, 2007·3 cites·10 claims
- 1866US2014235639A1Novel compoundsGLAXO GROUP LTD·Filed 2014·Application pending·0 cites
- 1965US8143264B2Xanthine derivatives as selective HM74A agonistsHATLEY RICHARD JONATHAN DANIEL·Filed 2006·Granted Mar 27, 2012·1 cites·16 claims
- 2063US6924297B2Naphathalene derivatives which bind to the EP4 receptorSMITHKLINE BEECHAM CORP·Filed 2001·Granted Aug 2, 2005·2 cites·13 claims
- 2161US7329685B21-Phenyl-2-oxo-3-sulfonylamino-pyrrolidine derivatives and related compounds as factor Xa inhibitors for the treatment of acute vascular diseasesGLAXO GROUP LTD·Filed 2004·Granted Feb 12, 2008·1 cites·8 claims
- 2259US7517879B2Pyrrolidine derivatives as factor Xa inhibitorsGLAXO GROUP LTD·Filed 2006·Granted Apr 14, 2009·0 cites·18 claims
- 2359US7429587B2Pyrrolidine derivatives as factor Xa inhibitorsGLAXO GROUP LTD·Filed 2006·Granted Sep 30, 2008·0 cites·14 claims
- 2459US7326785B2Pyrrolidine derivatives as factor XA inhibitorsGLAXO GROUP LTD·Filed 2006·Granted Feb 5, 2008·0 cites·3 claims
- 2559US2012202811A1Novel compoundsBORTHWICK ALAN DAVID·Filed 2012·Application pending·0 cites
- 2658US7288564B2Indole derivativesGLAXO GROUP LTD·Filed 2001·Granted Oct 30, 2007·1 cites·8 claims
- 2758US2015157640A1Novel compoundsGLAXO GROUP LTD·Filed 2015·Application pending·0 cites
- 2855US2007088068A1Benzo[F]Isoindole Derivatives With Affinity To The EP4 ReceptorCONGREVE MILES S·Filed 2006·Application pending·0 cites
- 2946US2008250977A1Oxime free anti-skinning combinationMASON ANDREW·Filed 2007·Application pending·0 cites
- 3044US2007191378A1Anthranilic acid derivatives and their use as activators of the hm74a receptorSMITHKLINE BEECHAM CORP·Filed 2004·Application pending·0 cites
- 3143US2008221108A1Anthranilic Acid Derivatives As Hm74A Receptor AgonistsHATLEY RICHARD·Filed 2006·Application pending·0 cites
- 3243US2004039020A1Novel pharmaceutical formulation suitable for nebulisationFiled 2001·Application pending·0 cites
- 3340US2008214638A1Anthranilic Acid Derivatives Active as the Hm74a ReceptorMASON ANDREW MCMURTRIE·Filed 2006·Application pending·0 cites
- 3440US2008139565A1Anthranilic Acid Derivatives and Their Use in Treatment of Diseases of Lipid Metabolism, in Particular DyslipidaemiaCAMPBELL MATTHEW·Filed 2006·Application pending·0 cites
- 3540US2007185162A1Substituted diketopiperazines as oxytocin receptor antagonistsKONINKL PHILIPS ELECTRONICS NV·Filed 2005·Application pending·0 cites
- 3639US2005059726A1Pyrrolidine-2-ones as factor xa inhibitorsFiled 2002·Application pending·0 cites
- 3738US2011257205A1Xanthine derivatives as selective hm74a agonistsHATLEY RICHARD JONATHAN DANIEL·Filed 2011·Application pending·0 cites
- 3836US2004037784A1Dry-powder pharmaceutical formulation for inhalation comprising alpha4-integrin antagonistFiled 2001·Application pending·0 cites
- 3936US2004034058A1Novel pharmaceutical formulation suitable for nebulisationFiled 2001·Application pending·0 cites
- 4036US2004034062A1Novel aqueous anti-inflammatory pharmaceutical formulationFiled 2001·Application pending·0 cites
- 4135US2004039021A1Pharmaceutical anti-inflammatory aerosol formulationFiled 2001·Application pending·0 cites
- 4235US2004044035A1Novel aqueous anti-inflammatory pharmaceutical formulationFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Andrew Mcmurtrie Mason files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →